A Phase IIa Randomized, Double-Blind, Parallel-Group, Placebo and Active-Controlled, Clinical Trial to Study the Efficacy and Safety of MK0974 Co-Administered With Ibuprofen or Acetaminophen in Patients With Migraine With or Without Aura.

Trial Profile

A Phase IIa Randomized, Double-Blind, Parallel-Group, Placebo and Active-Controlled, Clinical Trial to Study the Efficacy and Safety of MK0974 Co-Administered With Ibuprofen or Acetaminophen in Patients With Migraine With or Without Aura.

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Jun 2017

At a glance

  • Drugs Ibuprofen; Paracetamol; Telcagepant
  • Indications Migraine with aura; Migraine without aura
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 30 Aug 2011 New source identified and integrated (Clinical Trials Registry - India; CTRI2009-091-000291).
    • 27 Jun 2010 Results were reported at the 52nd Annual Scientific Meeting of the American Headache Society.
    • 09 Oct 2009 Actual end date changed from Aug 2009 to Sep 2009 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top